Last checked at Today 08:55
LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April
(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News4
GSK Share
Chat2
GSK Share
Trades2,869
GSK
Live RNS1
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,785.50
Bid:
1,785.00
Ask:
1,785.50
Change:
7.50 (0.42%)
Spread:
0.50 (0.028%)
Open:
1,780.00
High:
1,787.50
Low:
1,766.50
Prev. Close:
1,778.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Trial for vaccine against Ebola set to start in Oxford
Wed, 17th Sep 2014 10:10
Sixty healthy Britons will take part in a trial for a vaccine against Ebola at Oxford.The volunteers will be injected with the virus by experts at the University of Oxford in a fast-tracked process which aims to stop the spread of the fatal disease.The vaccine was developed by the US National Institutes of Health (NIH) and UK drug company GlaxoSmithKline.A grant of £2.8m was given by the Wellcome Trust, the Medical Research Council and the UK Department for International Development to the university in order to quickly find a vaccine to combat the virus.Professor Adrian Hill, director of the Jenner Institute at the University of Oxford, conducted the tests of the vaccine alongside similar trials in the USA.Hill said last month: “The tragic events unfolding in Africa demand an urgent response. In recent years, similar investigational vaccines have safely immunised infants and adults against a range of diseases including malaria, HIV and Hepatitis C.“We, and all our partners on this project, are optimistic that this candidate vaccine may prove useful against Ebola.”International development secretary Justine Greening said: “Britain is a world leader in medical research and mobilising our unique strengths to find a vaccine could be pivotal to containing Ebola and preventing future outbreaks.”Liberia, Sierra Leone and Guinea are the countries that have been worst-hit by the outbreak, which has so far caused the deaths of more than 2,400 people, half of which were in Liberia.However, patients have been successfully treated by experimental treatments in America.The US is planning to send 3,000 troops to Liberia in a bid to tackle the Ebola virus, officials revealed on Monday.US President Barack Obama is sending the military support to help construct new treatment centres, distribute homecare kits and aid in the training of staff, the White House said.A meeting has been convened by United Nations officials to plans an international response to the crisis.
More News
Today 08:36
TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case
(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.
Read moreToday 07:52
LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal
(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.
Read moreToday 07:30
Jury rules in favour of GSK in Zantac trial
(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.
Read more23 May 2024 19:21
Zantac not a cause of woman’s cancer, jury says in first trial over drug
CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.
Read more22 May 2024 22:59
What to know about bird flu in dairy cows and the risk to humans
CHICAGO, May 22 (Reuters) -
Read more21 May 2024 11:23
AstraZeneca aims for $80 bln in total revenue by 2030
Sees $80 bln in 2030 revenue by 2030
*Read more21 May 2024 08:49
GSK's depemokimab asthma treatment meets endpoints in latest trials
(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.
Read more21 May 2024 07:21
GSK reports promising results from asthma treatment trials
(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.
Read more20 May 2024 16:11
IN BRIEF: GSK executive buys GBP20,026 worth shares
GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.
Read more17 May 2024 17:38
London's FTSE nudges lower for week after record run
Haleon falls after GSK offloads remaining stake
*Read more17 May 2024 15:52
London close: Stocks recoup some earlier losses
(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.
Read more17 May 2024 11:52
LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady
(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.
Read more17 May 2024 09:03
TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion
(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.
Read more17 May 2024 08:56
LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends
(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.
Read more